The prescription of L-Carnitine in the treatment of Non-alcoholic fatty liver disease; A randomized and controlled clinical trial
Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2014, Vol 2, Issue 4
Abstract
Non-alcoholic fatty liver disease (NAFLD) consists of a range of consumption. The disease comprises clinical, Para clinical and pathological conditions from simple steatosis in non-alcoholic steatohepatitis (NASH) to fibrosis, cirrhosis and finally to hepatocellular carcinoma. The purpose of this study is to evaluate the grade of fatty liver and LFT in NAFLD patients. 80 patients referred to gastrointestinal clinic of Emam Reza hospital with sonography diagnosed NAFLD were evaluated in two groups in a randomized clinical trial. The effects of BID dose of L-Carnitine (500 mg) on liver enzymes and echogenicity changes in case group was documented and compared with control group. The mean age of the patients was 40.7±8 in the age range of 25 to 62 years old. 66 (82.5%) of the patients were male and 14 (17.5%) of them were female. Fatty liver changes were not significantly different in the two groups (P=0.23). After a 24-week interval, the ALT was the only enzyme with significant changes (P=0.01). The difference in fatty liver sonographic grading was also significant in the two groups (P=0.0001). Considering the significant changes both in enzymatic levels and sonographic grading between the two groups of patients with NAFLD, proper therapeutic protocols can be adopted beside diet and weight loss to control the disease trend.
Authors and Affiliations
Mohamad Hosein Somi, Ebrahim Fatahi, Jafar Panahi, MohamadReza Havasian, Arezo Judaki
FORMULATION DEVELOPMENT AND EVALUATION OF GLICLAZIDE GEL USING WATER SOLUBLE SODIUM CARBOXY METHYL CELLULOSE POLYMER
High molecular weights water soluble homopolymer of Sodium Carboxy Methyl Cellulose (Sodium CMC) are reported to possess very high viscosity in low concentration, transparency, film forming properties and are useful in...
Minimally invasive treatment for drug induced gingival enlargement-case report
Antihypertensive drugs in the calcium channel blocker group are extensively used in elderly patients. Gingival enlargement associated with Nifedipine was first reported in 1980’s and is very rarely reported to be assoc...
Amlodipine: the upcoming threat to Periodontist
Gingival hyperplasia is one of the side effects commonly caused by three major groups of drugs such as a) anticonvulsants b) antihypertensives – calcium channel blockers c) immunosuppressants. Previously among antihype...
Investigation of Oxygen absorbent in food packages
Active packaging is one of the newest concepts in food packages uses in order to supply the customer demands in shortest time. To prepare targeted foods, globalization of food market, transferring to longer distances,...
Amaranthus spinosus leaf extracts and its anti-inflamatory effects on cancer
The fruits and vegetables generate phytochemicals by its nature such as flavonoids and antioxidants which can reduce the oxidative stress and lower risk of chronic sustainment like cancer. The present study was to inve...